Live
CellLight-directed evolution of dynamic, multi-state, and computational protein functionalitiesCellSelective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosisCellDynamics of natural selection preceding human viral epidemics and pandemicsCellDeltaviruses spread through a viral Trojan HorseCellβ-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerIlluminaAssessing Illumina (ILMN) Valuation After Recent Share Price Weakness - simplywall.stLonza NewsWill Lonza Group AG (Common Stock) (LO3A) stock beat growth indexes - Short Setup & Smart Investment Allocation Tips - Naître et grandirThermo FisherNeo Ivy Capital Management Buys 3,865 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaNeo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeatEndpoints NewsUniQure’s dispute with FDA; Zealand’s obesity readout; China takes on world’s most expensive medicines; and moreWatersRep. Kevin Hern Shares of Waters Corporation (NYSE:WAT) - MarketBeatLonza NewsLonza sells off its capsules division to British firm - SWI swissinfo.ch
FierceBiotech Jan 21, 2026

FDA outlines draft policy on MRD, complete response for accelerated approvals in multiple myeloma

FDA outlines draft policy on MRD, complete response for accelerated approvals in multiple myeloma

Original
Body unavailable. Use the original source.

Directory

59 All